Journal Article

Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial

Gallagher, James W, Punchai, Suriya, Lang, Wei, Jakicic, John M, Courcoulas, Anita P, Gourash, William, DeLany, James P, Neiberg, Rebecca H, Eagleton, Emily B

2020

Overview

Abstract Context Questions remain about bariatric surgery for type 2 diabetes mellitus (T2DM) treatment. Objective Compare the remission of T2DM following surgical or nonsurgical treatments. Design, setting, and participants Randomized controlled trial at the University of Pittsburgh, in the United States. Five-year follow-up from February 2015 until June 2016. Interventions 61 participants with obesity and T2DM who were initially randomized to either bariatric surgical treatments (Roux-en-Y gastric bypass [RYGB] or laparoscopic adjustable gastric banding [LAGB]) or an intensive lifestyle weight loss intervention (LWLI) program for 1 year. Lower level lifestyle weight loss interventions (LLLIs) were then delivered for 4 years. Main Outcomes and Measures Diabetes remission assessed at 5 years. Results The mean age of the patients was 47 ± 6.6 years, 82% were women, and 21% African American. Mean hemoglobin A1c level 7.8% ± 1.9%, body mass index (BMI) 35.7 ± 3.1 kg/m2, and 26 participants (43%) had BMI < 35 kg/m2. Partial or complete T2DM remission was achieved by 30% (n = 6) of RYGB, 19% (n = 4) of LAGB, and no LWLI participants (P = .0208). At 5 years those in the RYGB group had the largest percentage of individuals (56%) not requiring any medications for T2DM compared with those in the LAGB (45%) and LWLI (0%) groups (P = .0065). Mean reductions in percent body weight at 5 years was the greatest after RYGB 25.2% ± 2.1%, followed by LAGB 12.7% ± 2.0% and lifestyle treatment 5.1% ± 2.5% (all pairwise P < .01). Conclusions Surgical treatments are more effective than lifestyle intervention alone for T2DM treatment.

• Publisher: Oxford University Press
• Subject: Adult / Bariatric Surgery / Body mass index / Body weight / Body weight loss / Care and treatment / Clinical s / Combined Modality Therapy / Development and progression / Diabetes / Diabetes mellitus (non-insulin dependent) / Diabetes Mellitus, Type 2 - blood / Diabetes Mellitus, Type 2 - epidemiology / Diabetes Mellitus, Type 2 - surgery / Diabetes Mellitus, Type 2 - therapy / Female / Follow-Up Studies / Gastric bypass / Gastrointestinal surgery / Glycated Hemoglobin A - drug effects / Glycated Hemoglobin A - metabolism / Hemoglobin / Humans / Hypoglycemic Agents - therapeutic use / Intervention / Laparoscopy / Life Style / Lifestyles / Male / Middle Aged / Obesity / Remission / Remission Induction / Risk Reduction Behavior / Surgery / Treatment Outcome / Type 2 diabetes / Weight Reduction Programs